Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
210.00    -2.50 (-1.18%)
Bid:
205.00
Ask:
215.00
Spread: 10.00 (4.878%)
Market Cap: £63.15m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Full Year Trading update

16 Jan 2025 07:00

RNS Number : 4994T
Mpac Group PLC
16 January 2025
 

16 January 2025

AIM: MPAC

 

Mpac Group plc

(''Mpac'', "Company" or "Group")

 

Full Year Trading update

 

FY24 trading performance in line with market expectations, a healthy opening order book for 2025 and good initial progress made on integrating H2 24 acquisitions

 

 

Mpac Group plc, a global leader in high-speed packaging and automation solutions, today announces a trading update (unaudited) for the year ended 31 December 2024 ("FY24").

 

The Board is pleased with the Group's FY24 performance and expects that it will report underlying profit before tax in line with market expectations of £10.5m (FY23: £7.1m). As anticipated, profit before tax in H2 24 was substantially above H1 24, aided by improving project margins and operational efficiencies.

 

The Group successfully executed the acquisitions of BCA Automation and CSi Palletising in H2 24 (the "Acquisitions"). The Acquisitions have continued to perform in line with the Board's expectations. The integration is progressing well and according to plan.

 

After the completion of the Acquisitions, the Group closes FY24 with net debt of £37.0m (FY23: net cash £2.1m) and a reduction in working capital to £7.0m (FY23: £13.2m), which includes circa £8.0m of invoiced receivables, due in 2024, most of which has been received in early January 2025. The Group remains on track to bring net debt down to less than 1 times EBITDA by the end of 2025.

 

Quote activity and the prospect pipeline within the growth sectors in which Mpac operates of Healthcare and Food and Beverage continues to be strong and following the Acquisitions, the Group ended FY24 with an increased value of the closing order book at c.£111.0m (FY23: £72.5m) providing good coverage over 2025 forecast revenue. 

 

With an increasingly diverse prospect pipeline and order book and good quote activity, as well as a stronger offering through combined product lines from our existing and acquired businesses, the Group is well placed to deliver on market expectations for the current financial year and beyond. The Board remains confident that the Group will continue progressing its long-term growth strategy.

 

Adam Holland, Chief Executive, commented:

 

We are pleased with full year 2024 financial performance, which is in line with market expectations. 2024 has proved to be a transformational year for the Group, with the acquisitions of CSi, BCA and Siga Vision providing the platform for a step change in scale and profitability, accelerating our progress towards our strategic objectives. The acquisitions materially diversify the Group's portfolio enabling the Group to provide a fuller line offering, as well as access to new customer relationships providing a platform for continued robust organic growth.

 

We would like to thank shareholders for their support of the acquisition of CSi and their ongoing support as we head into 2025. We anticipate reporting for 2024 record levels of revenue, with underlying profit before tax breaking through the £10m mark for the first time. We start 2025 with a larger and more diverse order book from our resilient end markets providing a high level of coverage over forecast revenue, supporting delivery of our expectations for further growth in the year ahead.''

 

The Group's full year results for the year ended 31 December 2024 are expected to be announced in the week commencing 28 April 2025, allowing for the additional time required to complete the first audit of the enlarged Group following the recent significant acquisitions.

 

 

For further information, please contact:

Mpac Group plc

Adam Holland, Chief Executive

Will Wilkins, Chief Financial Officer

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Advisory

Patrick Castle

Sophie Collins

Broking

Henry Willcocks

 

 

Tel: +44(0)20 7408 4050

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Will King

Anake Singh

 

Hudson Sandler (Financial PR)

Nick Lyon

Nick Moore

Francesca Rosser

Tel: +44 (0) 20 3100 2000

 

 

 

 

Tel: +44 (0) 20 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUCCGUPAGMA
Date   Source Headline
16th Jun 20174:36 pmRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSGrant of Options
8th Jun 20177:00 amRNSProposed sale of division & notice of GM
20th Apr 20172:33 pmRNSResult of AGM
4th Apr 201710:43 amRNSHolding(s) in Company
2nd Mar 20177:00 amRNSFinal Results for the year to 31 December 2016
27th Feb 20173:56 pmRNSNotice of Results
16th Jan 20172:00 pmRNSPrice Monitoring Extension
24th Aug 20167:00 amRNSHalf-year Report
25th May 20163:32 pmRNSDirector Dealings and Holdings in Company
11th May 20167:00 amRNSBoard Changes
22nd Apr 20161:44 pmRNSResult of AGM
22nd Apr 201611:47 amRNSAGM Statement
15th Apr 201610:58 amRNSHolding(s) in Company
29th Mar 20169:32 amRNSNotice of AGM
25th Feb 20167:00 amRNSPreliminary Results
4th Nov 20152:40 pmRNSDirector/PDMR Shareholding
27th Aug 20157:00 amRNSHalf Yearly Report
17th Jun 20154:46 pmRNSHolding(s) in Company
10th Jun 20156:04 pmRNSHolding(s) in Company
1st Jun 20157:00 amRNSDisposal
24th Apr 20151:27 pmRNSResult of AGM
24th Apr 201511:55 amRNSAGM Trading Statement
10th Apr 20159:00 amRNSBoard changes
25th Feb 20157:00 amRNSFinal Results
31st Oct 201410:49 amRNSHolding(s) in Company
10th Oct 20142:31 pmRNSTrading update
28th Aug 20147:00 amRNSHalf Yearly Report
19th Jun 20148:30 amRNSAdmission to AIM
19th Jun 20148:00 amRNSCancellation - MOLINS PLC
20th May 201411:32 amRNSSchedule 1 - Molins Plc
20th May 201411:20 amRNSResult of GM & Schedule 1 announcement
24th Apr 20146:39 pmRNSResult of AGM
24th Apr 201411:10 amRNSInterim Management Statement
24th Apr 201411:10 amRNSProposed admission to trading on AIM
28th Feb 201410:28 amRNSRDS Director/PDMR Shareholding
26th Feb 20147:00 amRNSFinal Results
7th Feb 20147:00 amRNSNotification of Preliminary Results
23rd Dec 20137:00 amRNSChange of Adviser
5th Dec 20137:00 amRNSPurchase of shares by Molins PLC Employee Trust
8th Nov 20131:10 pmRNSHolding(s) in Company
25th Oct 201311:56 amRNSHolding(s) in Company
24th Oct 201312:33 pmRNSHolding(s) in Company
24th Oct 20137:00 amRNSInterim Management Statement
16th Oct 201310:58 amRNSHolding(s) in Company
12th Sep 20134:17 pmRNSHolding(s) in Company
5th Sep 20136:21 pmRNSHolding(s) in Company
2nd Sep 20136:07 pmRNSHolding(s) in Company
29th Aug 20137:00 amRNSFinal Results
25th Jul 20131:30 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.